ABSTRACT
Polycystic ovary syndrome (PCOS) is a common, complex genetic disorder. Its inherited basis was established by studies demonstrating an increased prevalence of PCOS and hyperandrogenemia, insulin resistance, and disordered insulin secretion in relatives of women with PCOS. To date, efforts in elucidating the genetic basis of PCOS have focused on candidate genes chosen from logical pathways, such as steroid synthesis or insulin signaling. Whereas several positive results have been reported, no genes are universally accepted as important in PCOS pathogenesis, largely due to lack of replication of positive results. This has resulted, in part, from various factors, most importantly lack of a universally accepted diagnostic scheme for PCOS, ability to assign PCOS diagnosis only in women of reproductive age, inadequate coverage of genes by the analysis of only one or two variants, and of small case-control cohorts in most studies. Candidate gene selection has been limited by our incomplete knowledge of the pathophysiology of PCOS. In the future, strict and uniform diagnostic criteria, improved application of the candidate gene approach using haplotype-based analyses, intermediate phenotypes, replication of positive results in large cohorts, more family-based studies, gene selection from expression studies, and whole-genome approaches will enhance gene discovery in PCOS.
KEYWORDS
Candidate gene - association - replication - single nucleotide polymorphism - haplotype
REFERENCES
1 King R A, Rotter J I, Motulsky A G. The Genetic Basis of Common Diseases. 2nd ed. New York, NY; Oxford University Press 2002
2
Goodarzi M O, Azziz R.
Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome.
Best Pract Res Clin Endocrinol Metab.
2006;
20
193-205
3
Parikh H, Groop L.
Candidate genes for type 2 diabetes.
Rev Endocr Metab Disord.
2004;
5
151-176
4
Pall M, Stephens K, Azziz R.
Family size in women with polycystic ovary syndrome.
Fertil Steril.
2006;
85
1837-1839
5
Nam Menke M, Strauss J F.
Genetics of polycystic ovarian syndrome.
Clin Obstet Gynecol.
2007;
50
188-204
6
Franks S, McCarthy M.
Genetics of ovarian disorders: polycystic ovary syndrome.
Rev Endocr Metab Disord.
2004;
5
69-76
7
Escobar-Morreale H F, Luque-Ramirez M, San Millan J L.
The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.
Endocr Rev.
2005;
26
251-282
8
Diamanti-Kandarakis E, Piperi C.
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.
Hum Reprod Update.
2005;
11
631-643
9
Urbanek M.
The genetics of the polycystic ovary syndrome.
Nat Clin Pract Endocrinol Metab.
2007;
3
103-111
10
Unluturk U, Harmanci A, Kocaefe C, Yildiz B O.
The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma.
PPAR Res.
2007;
49109
11
Thomas D C, Witte J S.
Point: population stratification: a problem for case-control studies of candidate-gene associations?.
Cancer Epidemiol Biomarkers Prev.
2002;
11
505-512
12
Wacholder S, Rothman N, Caporaso N.
Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer.
Cancer Epidemiol Biomarkers Prev.
2002;
11
513-520
13
Goodarzi M O, Shah N A, Antoine H J et al..
Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
J Clin Endocrinol Metab.
2006;
91
4085-4091
14
Carmina E, Legro R S, Stamets K, Lowell J, Lobo R A.
Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet.
Hum Reprod.
2003;
18
2289-2293
15 Beavis W D. QTL analyses: power, precision, and accuracy . In: Paterson AH Molecular Dissection of Complex Traits. New York, NY; CRC Press 1998: 145-162
16
Wild R A, Vesely S, Beebe L, Whitsett T, Owen W.
Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome.
J Clin Endocrinol Metab.
2005;
90
4112-4114
17 Zawadzki J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach . In: Dunaif A, Givens JR, Haseltine F, Merriam GR Polycystic Ovary Syndrome. Cambridge, MA; Blackwell Scientific 1992: 377-384
18
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Fertil Steril.
2004;
81
19-25
19
Urbanek M, Legro R S, Driscoll D A et al..
Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.
Proc Natl Acad Sci USA.
1999;
96
8573-8578
20
Urbanek M, Woodroffe A, Ewens K G et al..
Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2
J Clin Endocrinol Metab.
2005;
90
6623-6629
21
Stewart D R, Dombroski B, Urbanek M et al..
Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.
J Clin Endocrinol Metab.
2006;
91
4112-4117
22
Gabriel S B, Schaffner S F, Nguyen H et al..
The structure of haplotype blocks in the human genome.
Science.
2002;
296
2225-2229
23
The International HapMap Consortium .
The International HapMap Project.
Nature.
2003;
426
789-796
24
Horikawa Y, Oda N, Cox N J et al..
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.
Nat Genet.
2000;
26
163-175
25
Vollmert C, Hahn S, Lamina C et al..
Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
Am J Physiol Endocrinol Metab.
2007;
292
E836-E844
26
Gonzalez A, Saez M E, Aragon M J et al..
Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome.
Hum Reprod.
2006;
21
943-951
27
Petry C J, Ong K K, Michelmore K F et al..
Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.
Hum Reprod.
2005;
20
1837-1843
28
Goodarzi M O, Antoine H J, Pall M et al..
Preliminary evidence of glycogen synthase kinase 3 beta as a genetic determinant of polycystic ovary syndrome.
Fertil Steril.
2007;
92
2659-2664
29
Goodarzi M O, Antoine H J, Azziz R.
Genes for enzymes regulating DHEA sulfonation are associated with levels of DHEA-sulfate in polycystic ovary syndrome.
J Clin Endocrinol Metab.
2007;
92
2659-2664
30
Jones M R, Wilson S G, Mullin B H et al..
Polymorphism of the follistatin gene in polycystic ovary syndrome.
Mol Hum Reprod.
2007;
13
237-241
31
Petry C J, Ong K K, Wingate D L et al..
Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.
J Steroid Biochem Mol Biol.
2007;
105
176-180
32
Jones M R, Italiano L, Wilson S G et al..
Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
Fertil Steril.
2006;
86
1438-1446
33
Purcell S, Cherny S S, Sham P C.
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
Bioinformatics.
2003;
19
149-150
34
Spielman R S, McGinnis R E, Ewens W J.
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).
Am J Hum Genet.
1993;
52
506-516
35
Hughes C, Elgasim M, Layfield R, Atiomo W.
Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review.
Hum Reprod.
2006;
21
2766-2775
36
Ho C K, Wood J R, Stewart D R et al..
Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells.
J Clin Endocrinol Metab.
2005;
90
6596-6602
37
Saxena R, Voight B F, Lyssenko V et al..
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
Science.
2007;
316
1331-1336
38
Scott L J, Mohlke K L, Bonnycastle L L et al..
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
Science.
2007;
316
1341-1345
39
Sladek R, Rocheleau G, Rung J et al..
A genome-wide association study identifies novel risk loci for type 2 diabetes.
Nature.
2007;
445
881-885
40
Zeggini E, Weedon M N, Lindgren C M et al..
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
Science.
2007;
316
1336-1341
Mark O GoodarziM.D. Ph.D.
8700 Beverly Blvd.
Room B-131, Los Angeles, CA 90048
Email: mark.goodarzi@cshs.org